Noninvasive device monitoring of sarcopenia
This project has been secured to protect intellectual property.
Login for More InformationA device that is capable of monitoring and tracking of muscle characteristics, including mass, muscle to fat ratio, and quality of the muscle.
Project Overview
Sarcopenia is a condition that impacts 5-13% of individuals over the age of 60-70, and 11-50% of individuals over the age of 80 [1]. It is defined as a skeletal muscle disorder that accelerates the loss of muscle mass and function, and can lead to increased fall risk, frailty, and overall morbidity [2]. Current methods of measuring muscle mass for diagnosis of the condition include Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and dual energy X-ray absorptiometry (DXA) [2]. Oftentimes these measurements are performed in conjunction with a questionnaire, SARC-F, that evaluates a patient’s subjective perception of their overall strength and mobility [2]. However, these approaches are not widely recognized by physicians, and are typically time-consuming, expensive, and inaccessible to many patients [3]. There is therefore a need for a novel diagnostic device that enables fast, affordable, and accessible measurement and tracking of muscle mass changes over time to support early detection and ongoing monitoring of sarcopenia.
[1] S. von Haehling, J. E. Morley, and S. D. Anker, “An overview of sarcopenia: facts and numbers on prevalence and clinical impact,” J. Cachexia Sarcopenia Muscle, vol. 1, no. 2, pp. 129–133, Dec. 2010, doi: 10.1007/s13539-010-0014-2.
[2]A. J. Cruz-Jentoft and A. A. Sayer, “Sarcopenia,” The Lancet, vol. 393, no. 10191, pp. 2636–2646, Jun. 2019, doi: https://doi.org/10.1016/s0140-6736(19)31138-9.
[3]A. A. Sayer and A. Cruz-Jentoft, “Sarcopenia definition, diagnosis and treatment: consensus is growing,” Age and Ageing, vol. 51, no. 10, Oct. 2022, doi: https://doi.org/10.1093/ageing/afac220.
Team Picture

Contact Information
Team Members
- Lucia Frieling - Team Leader
- Lia Lejonvarn - Communicator
- Elaina Rizzo - BSAC
- Amanda Kothe - BWIG
- Liv Baumann - BPAG
- Elizabeth Collinson
Advisor and Client
- Prof. Paul Campagnola - Advisor
- Dr. Ken Lee - Client
Related Projects
- Fall 2025: Noninvasive device monitoring of sarcopenia
- Spring 2025: Noninvasive device monitoring of sarcopenia
- Fall 2024: Noninvasive device monitoring of sarcopenia
- Fall 2023: Noninvasive device monitoring of sarcopenia